Clinical Trials in Tennessee

Showing 2781-2800 of 9,675 trials

A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer

NCT05441501

The purpose of this study is to determine recommended phase 2 dose(s) (RP2Ds) of JNJ-80038114 in Part 1 (dose escalation) and to determine the safety at the RP2D(s) in Part 2 (dose expansion).

Prostatic Neoplasms

Janssen Research & Development, LLC39 participantsStarted Nov 2022

Minneapolis, Minnesota, United States • Philadelphia, Pennsylvania, United States • Nashville, Tennessee, United States +3 more locations

COMPLETEDPhase 229 miles

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

NCT04417530

The primary objective is to determine the safety, tolerability, and preliminary efficacy of belzupacap sarotalocan for the treatment of primary indeterminate lesions and small choroidal melanoma (IL/CM).

Uveal MelanomaOcular MelanomaChoroidal Melanoma

Aura Biosciences22 participantsStarted Aug 2020

Tucson, Arizona, United States • Los Angeles, California, United States • Palo Alto, California, United States +19 more locations

A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Find Trials by Condition in Tennessee

XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer

A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

A Phase 2b Study of Icosabutate in Fatty Liver Disease

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

ThRombosis ExclUsion STudy

An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension

Multicenter Hologic Tomosynthesis Study

FREEOAB Study for Overactive Bladder

Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis

EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC

Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

Study to Evaluate the OrthoCor Active System for Pain Relief

An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice